Related references
Note: Only part of the references are listed.Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: An updated systematic review and meta-analysis of 30 trials
Fausto Petrelli et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer
Randall J. Kimple et al.
CANCER RESEARCH (2013)
Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer
Daniel W. Vermeer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity
Thorsten Rieckmann et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells
Brita Singers Sorensen et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Immunologically augmented cancer treatment using modern radiotherapy
Marco Durante et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Microenvironment and Radiation Therapy
Michio Yoshimura et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
Kasper Toustrup et al.
RADIOTHERAPY AND ONCOLOGY (2012)
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial
Lise Sakso Mortensen et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Human Papillomavirus as a Marker of the Natural History and Response to Therapy of Head and Neck Squamous Cell Carcinoma
Kie Kian Ang et al.
SEMINARS IN RADIATION ONCOLOGY (2012)
Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis
Maura L. Gillison et al.
VACCINE (2012)
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar et al.
VACCINE (2012)
RADIOSENSITIZATION OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA CELLS BY HUMAN PAPILLOMAVIRUS 16 ONCOPROTEIN E6*I
Ervinna Pang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Proteasomal Degradation of p53 by Human Papillomavirus E6 Oncoprotein Relies on the Structural Integrity of p53 Core Domain
Xavier Bernard et al.
PLOS ONE (2011)
Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer
Elaine M. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
Pernille Lassen et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice
Sean Jabbar et al.
VIROLOGY (2010)
Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus-Related Head and Neck Cancer
William C. Spanos et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts
Chih-Wen Tseng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS
Christina S. Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
Pernille Lassen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
Theodore Rampias et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Adoptive Transfer of Human Papillomavirus E7-specific CTL Enhances Tumor Chemoresponse Through the Perforin/Granzyme-mediated Pathway
Jeong-Im Sin et al.
MOLECULAR THERAPY (2009)
Oncogenic activities of human papillomaviruses
Margaret E. McLaughlin-Drubin et al.
VIRUS RESEARCH (2009)
CD47 in the Immune Response: Role of Thrombospondin and SIRP-alpha Reverse Signaling
Marika Sarfati et al.
CURRENT DRUG TARGETS (2008)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein
Jennifer A. Regan et al.
JOURNAL OF VIROLOGY (2008)
gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
Andrea Kinner et al.
NUCLEIC ACIDS RESEARCH (2008)
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects
Chih Wen Tseng et al.
VACCINE (2008)
Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer
Katerina Strati et al.
CANCER RESEARCH (2007)
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M. Obeid et al.
CELL DEATH AND DIFFERENTIATION (2007)
Case-control study of human papillomavirus and oropharyngeal cancer
Gypsyamber D'Souza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High number of intraepithelial CD8(+) tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer
Sytse J. Piersma et al.
CANCER RESEARCH (2007)
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
Lisa Licitra et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia:: Implications for anticancer therapies
Philippe Martinive et al.
CANCER RESEARCH (2006)
HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300
Michael A. James et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx
TK Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck
A Albers et al.
CANCER RESEARCH (2005)
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review
AR Kreimer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer
PM Weinberger et al.
CLINICAL CANCER RESEARCH (2004)
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus
BJM Braakhuis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Failla Memorial Lecture - A sense of danger from radiation
WH McBride et al.
RADIATION RESEARCH (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1
T Iftner et al.
EMBO JOURNAL (2002)
Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy
AM Jastreboff et al.
POSTGRADUATE MEDICAL JOURNAL (2002)
Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
R Klaes et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
